Public Company News
JinkoSolar Announces Results of 2026 Annual General Meeting
SHANGRAO, China, Oct. 21, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), today announced that all shareholders resolutions proposed at the Company's 2026 annual general meeting held today were duly passed. Specifically, the Company's shareholders p...
2026-10-21 12:01
2540
Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical Value
* 64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and supportive care. * More than 10 studies have been selected to highlight the latest findings on HER2- and HER3-targeted anti...
2026-10-21 10:09
1916
AROA and Mölnlycke Partner to Expand U.S. Access to Endoform™
Exclusive co-promotion agreement combines AROA's regenerative tissue technology with Mölnlycke's wound care expertise and commercial reach AUCKLAND, New Zealand, Oct. 20, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, has entered into an exclusive ag...
2026-10-21 08:00
2305
Dogness Receives NASDAQ Notification Regarding Minimum Bid Price Requirement
DONGGUAN, China, Oct. 20, 2026 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM, and private-label pet products, today announced that on October 19, 2026, it received a let...
2026-10-21 04:15
3715
Insilico Medicine and Servier Achieve First Milestone in AI-Driven R&D Collaboration, Triggering An undisclosed Milestone Payment
* Two programs under the multi-year R&D collaboration have initiated and completed target nomination since its early 2026 announcement. * Insilico reached the first R&D milestone using its proprietary Pharma.AI platform, triggering an undisclosed milestone payment from Servier. * The multi-t...
2026-10-20 21:00
3603
Lunit Highlights AI-Powered Pathology Insights Across Cancer Types at ESMO 2026
Five studies to be presented, with key research examining AI-based biomarker assessment and tumor microenvironment analysis in breast, lung and pancreatic cancers SEOUL, South Korea, Oct. 20, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision ...
2026-10-20 21:00
2906
Yuchai and Guangxi Zhenye Form New Joint Venture
SINGAPORE, Oct. 20, 2026 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai International" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery Company Limited ("Yuchai"), announ...
2026-10-20 20:00
4858
Planet Green Holdings Corp. Provides Response to Unusual Market Action
NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Planet Green Holdings Corp. ("Planet Green", the "Company") (NYSE American: PLAG) announced today that the Company had become aware of unusual trading activity in its common stock on the New York Stock Exchange American (the "NYSE") on October 19, 2026. The...
2026-10-20 20:00
4323
YYForce AI Humanoid Housekeepers to be trained in Novotel Hotel
Acquires 20 wearable data collection systems to capture real-world housekeeping tasks to support robot learning and development. SINGAPORE, Oct. 20, 2026 /PRNewswire/ -- YYForce Inc. (NASDAQ: YFOR) ("YYForce" or the "Company"), a technology-enabled provider of workforce solutions, integrated fac...
2026-10-20 19:07
2501
Lufax to Announce Third Quarter 2026 Financial Results on October 27, 2026
SHANGHAI, Oct. 20, 2026 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that it plans to release its third quarter 2026 financial results after the market closes on Tue...
2026-10-20 19:00
5007
Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion
* Founder Tim Johnson to become Executive Chairman, continuing to drive long-term strategy, technology innovation and product development * Leadership evolution designed to accelerate commercial execution, pursue strategic acquisitions and enhance long-term shareholder value * Experienced le...
2026-10-20 18:30
5099
Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication
Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 19, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today a...
2026-10-20 09:00
2404
WuXi AppTec Receives Frost & Sullivan's Global Company of the Year Recognition in CRDMO for Tenth Consecutive Year
SHANGHAI, Oct. 19, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received Frost & Sullivan's 2026 Global Company of the Year Recognition in the CRDMO industry for the tenth consecutive year. Frost & S...
2026-10-20 08:00
3151
Kingsoft Cloud Upgraded to "AAA" in MSCI ESG Rating
BEIJING, Oct. 19, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited (" Kingsoft Cloud" or the "Company") (NASDAQ: KC and HKEX: 3896), a leading cloud service provider in China, is pleased to announce that its Environmental, Social and Governance (ESG) rating by Morgan Stanley Capital Internatio...
2026-10-19 21:08
3493
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today announced that it has commenced to terminate its American Depositary...
2026-10-19 20:30
5545
Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer
SUZHOU, China and PRINCETON, N.J., Oct. 19, 2026 /PRNewswire/ -- Transcenta Therapeutics (HKEX: 06628) today announced that its Board of Directors has approved the appointment of Ms. Jennie Ma as Chief Financial Officer (CFO) of the Company. In this role, Ms. Ma will oversee the Company's financi...
2026-10-19 20:00
2213
Hyosung Chairman Hyun-Joon Cho Advances Bio-Based Materials Strategy with Commercial Bio-BDO Production in Vietnam
* Chairman Cho positions bio-based materials as a core pillar of Hyosung's long-term growth * Integrated production network connects sugarcane-derived raw materials to finished bio-based spandex * US$1 billion investment supports 50,000 metric tons of annual bio-BDO capacity, with phased ex...
2026-10-19 20:00
4554
Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma, Including Combination with Cadonilimab
HONG KONG, Oct. 19, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") and its partner Summit TherapeuticsInc. jointly announced an international multicenter Phase II clinical study (SMT112-216 / AK112-216 / NCT07877194). Built on Akeso's first-in-class immuno-oncology (IO) c...
2026-10-19 19:59
2255
Goodix Launches Integrated Fingerprint and Security Solution to Secure On-Device Identity Authentication in IoT and AI Devices
SHENZHEN, China, Oct. 19, 2026 /PRNewswire/ -- As AI phones and PCs, wearables, robots, smart-home products and intelligent cockpits become more intelligent and capable, secureidentity authentication is emerging as a foundational capability for IoT and AI edge devices. To meet this need, Goodix ...
2026-10-19 18:12
2742
ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Negative Breast Cancer
SHANGHAI, Oct. 18, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II clinical data onits Nectin-4-targeting antibody-drug conjugate (ADC) 9MW2821 (Bulumtatug Fuvedotin, "BFv") in locally...
2026-10-19 10:00
4058
Week's Top Stories
Most Reposted
Visa and Marina Bay Precinct Partners - Marina Bay Sands, UOB and Singapore Tourism Board - Present 'A Moment to Savour', Bringing International Restaurant Collaborations to Singapore
[Picked up by 310 media titles]
2026-10-27 13:40
Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 294 media titles]
2026-10-28 12:12
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00
OneQode Signs 14 MW AI Capacity Agreement with AdaniConneX, with a Path to 114 MW
[Picked up by 277 media titles]
2026-10-28 09:00
Pepperstone and Aston Martin Aramco extend and expand partnership with Fernando Alonso appointed Global Ambassador from 2027.
[Picked up by 276 media titles]
2026-10-29 13:01
Most Read
SwitchBot Launches AI Art Frame 2 with Full-Color E Ink and Personalized Art
2026-10-27 21:00
43241
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
33772
The Future of AI 3D Character Workflows: Reallusion CC 5.2 Turns Meshes into Living Characters
2026-10-29 20:03
18500
ROKAE delivers its 10,000th humanoid force-controlled arm
2026-10-27 00:00
16950
